BRPI0512948A - biomarcadores de mal de alzheimer - Google Patents

biomarcadores de mal de alzheimer

Info

Publication number
BRPI0512948A
BRPI0512948A BRPI0512948-6A BRPI0512948A BRPI0512948A BR PI0512948 A BRPI0512948 A BR PI0512948A BR PI0512948 A BRPI0512948 A BR PI0512948A BR PI0512948 A BRPI0512948 A BR PI0512948A
Authority
BR
Brazil
Prior art keywords
alzheimer
disease
biomarkers
test
diagnosing
Prior art date
Application number
BRPI0512948-6A
Other languages
English (en)
Inventor
Simon Lovestone
Original Assignee
King S College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King S College London filed Critical King S College London
Publication of BRPI0512948A publication Critical patent/BRPI0512948A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

BIOMARCADORES DE MAL DE ALZHEIMER Um teste para diagnóstico de mal de Alzheimer compreende medição dos níveis de GSK-3 em células ou fluido corporal em uma amostra tomada de um ser humano. O teste proporciona um método relativamente não invasivo de diagnóstico de mal de Alzheimer e pode ser útil na previsão de quais indivíduos com dano cognitivo brando desenvolverão mal de Alzheimer.
BRPI0512948-6A 2004-07-02 2005-07-01 biomarcadores de mal de alzheimer BRPI0512948A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0414894.6A GB0414894D0 (en) 2004-07-02 2004-07-02 Biomarkers of alzheimer's disease
PCT/GB2005/002592 WO2006003414A2 (en) 2004-07-02 2005-07-01 Biomarkers of alzheimer's disease

Publications (1)

Publication Number Publication Date
BRPI0512948A true BRPI0512948A (pt) 2008-04-15

Family

ID=32843494

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512948-6A BRPI0512948A (pt) 2004-07-02 2005-07-01 biomarcadores de mal de alzheimer

Country Status (9)

Country Link
US (1) US20080076140A1 (pt)
EP (1) EP1763674A2 (pt)
JP (1) JP2008504551A (pt)
CN (1) CN101010589A (pt)
AU (1) AU2005258926A1 (pt)
BR (1) BRPI0512948A (pt)
CA (1) CA2571692A1 (pt)
GB (1) GB0414894D0 (pt)
WO (1) WO2006003414A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8226927B2 (en) 2006-05-25 2012-07-24 Farhad Karimi 11C/18F-labeled inhibitors of glycogen synthase kinase-3
WO2009074331A2 (en) * 2007-12-11 2009-06-18 Julius-Maximilians-Universität Würzburg Early and differential diagnosis test for alzheimer's disease
WO2009114945A1 (en) 2008-03-21 2009-09-24 Neuman Manuela G Methods and kits for the differential diagnosis of alzheimer's disease versus frontotemporal dementia, and for the diagnosis of frontotemporal dementia, comprising fas-l and ckl 18 as biomarkers
US20100151457A1 (en) * 2008-12-17 2010-06-17 National Tsing Hua University Detection of Unhealthy Cell and Uses Thereof
US20120040361A1 (en) * 2010-07-22 2012-02-16 National Tsing Hua University Methods and compositions for detection of lethal system and uses thereof
CN104237526B (zh) * 2013-06-18 2016-08-17 磁量生技股份有限公司 一种检测阿兹海默症罹患风险的系统
CA2941650A1 (en) * 2014-03-05 2015-09-11 Humanetics Corporation Predicting and reducing cognitive decline based on gsk-3 levels
CN104698188A (zh) * 2015-03-04 2015-06-10 华中科技大学 检测人血小板GSK-3β蛋白活性的斑点印迹方法
CN111323597A (zh) * 2018-12-14 2020-06-23 陈志成 用于检测受试者中mci和/或ad的方法、试剂盒及筛选化合物的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2569083A1 (en) * 2004-05-07 2005-11-17 Garvan Institute Of Medical Research Detecting disease association with aberrant glycogen synthase kinase 3.beta. expression

Also Published As

Publication number Publication date
AU2005258926A1 (en) 2006-01-12
CA2571692A1 (en) 2006-01-12
WO2006003414A3 (en) 2006-03-16
US20080076140A1 (en) 2008-03-27
WO2006003414A2 (en) 2006-01-12
JP2008504551A (ja) 2008-02-14
EP1763674A2 (en) 2007-03-21
GB0414894D0 (en) 2004-08-04
CN101010589A (zh) 2007-08-01

Similar Documents

Publication Publication Date Title
BR0206604A (pt) Dispositivo de lanceta que tem ação capilar
ITRM20030386A0 (it) Metodo e test diagnostici basati sull'analisi citofluorimetrica dei linfociti t antigene-specifici.
WO2003075745A3 (en) Detection, diagnosis, and monitoring of a medical condition or disease with artificial olfactometry
EP1718334A4 (en) METHOD FOR DIAGNOSIS AND TREATMENT OF PREECLAMPSY OR ECLAMPSY
WO2008069975A3 (en) Methods of using f-spondin as a biomarker for cartilage degenerative conditions
WO2005034008A3 (en) A method of anonymous medical testing and providing the patient with the test results
EP2293075A3 (en) Method for diagnosing neuro-degenerative disease
DE602005015894D1 (de) Diagnostische testvorrichtung
BRPI0720035A2 (pt) métodos para tratar um paciente tendo uma doença ou distúrbio, para tratar um paciente com doença autoimune, para neutralizar um perfil de expressão do marcador pd indutível por ifn do tipo 1 ou ifnalfa em um paciente, para monitorar ou prognosticar progressão de doença autoimune de um paciente, para monitorar a progressão da doença de um paciente que recebe o tratamento com um agente terapêutico que liga-se a e modula a atividade de ifnalfa, para identificar um paciente como um candidato para um agente terapêutico que liga-se a e modula a atividade de ifnalfa, para diagnosticar um paciente como tendo um distùrbio associado com níveis aumentados de ifnalfa, para identificar um terapêutico candidato para o tratamento de distùrbios mediados por ifnalfa e para detectar atividade de ifn em uma amostra, conjunto de sondas, e, kit
EP1839056A4 (en) Preeclampsia-DIAGNOSIS
EP2520935A3 (en) Organ-specific proteins and methods of their use
MX2009004463A (es) Ensayo para anticuerpos de troponina cardiaca.
WO2006073682A3 (en) Diagnostic test
DE60228557D1 (de) Candida-nachweis
BRPI0512948A (pt) biomarcadores de mal de alzheimer
WO2008080030A3 (en) Cardiovascular autoimmune disease panel and methods of using same
EP1745739A3 (en) Optical imaging of rheumatoid arthritis
NZ599054A (en) Diagnosis of collagen IX destruction
DE602005011316D1 (de) Verfahren zur diagnose und behandlung von morbus crohn
ATE494556T1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
EP2071338A3 (en) Human diabetes-mediating proteins
MX2010002009A (es) Panel de salud de aparato reproductor masculino y usos del mismo.
BR0317404A (pt) Variantes do fator xiia
RU2003107336A (ru) Способ диагностики клинических типов школьной дезадаптации, установления особенностей возрастной динамики и прогноза дезадаптационных состояний детей с легкой умственной отсталостью
FR2828212B1 (fr) Methodes de diagnostic et de pronostic de la maladie de parkinson

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired